Skip to main content
. Author manuscript; available in PMC: 2018 May 8.
Published in final edited form as: Domest Anim Endocrinol. 2012 Oct 8;44(2):98–108. doi: 10.1016/j.domaniend.2012.09.005

Figure. 4.

Figure. 4

A. Steady state concentrations of JUN mRNA (ratio of JUN mRNA/GAPDH mRNA) at 0.5 h after PGF2α treatment in CL from gilts on Day 9 (n=4/5 per group) or Day 17 (n=5 per group). B. Steady state concentrations of JUND mRNA (normalized to ACTB mRNA) at 0.5 h after PGF2α treatment in CL from gilts on Day 9 (n=4/5 per group) or Day 17 (n=5 per group). *Denotes differences from paired control, P < 0.01.